SCHEMBL3944540

SCHEMBL3944540

COC(=O)Cc1ccc(OCc2ccccc2)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 1/20 0.57
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 3/20 0.50
MAOB P27338 2/20 0.49
MEN1 O00255 1/20 0.48
PABPC1 P11940 1/20 0.48
KMT2A Q03164 1/20 0.48
ALOX5 P09917 1/20 0.48
NR4A1 P22736 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
FFAR1 O14842 1/20 0.46
PRMT5 O14744 1/20 0.46
PARP10 Q53GL7 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
PTGS1 P23219 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30697582 0.86 PRMT5 (0.60) P4HTMALDH1A1MAOBMEN1KMT2A
SCHEMBL4166459 0.85 P4HTM (0.63) P4HTMMAOBMEN1KMT2AALOX5
SCHEMBL4170920 0.85 P4HTM (0.53) P4HTMMAOBMEN1KMT2AALOX5
SCHEMBL9314216 0.81 SMN1; SMN2 (0.44) NPC1RAB9ASMN1; SMN2ALDH1A1MEN1
SCHEMBL392863 0.81 ALOX5 (0.66) NPC1RAB9ASMN1; SMN2ALDH1A1MAOB
SCHEMBL15709788 0.81 MAPK1 (0.50) NPC1RAB9ASMN1; SMN2ALDH1A1MEN1
SCHEMBL38656596 0.81 FFAR1 (0.46) P4HTMNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL30106066 0.81 CYP11B1 (0.45) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL25033218 0.80 MEN1 (0.55) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL1572841 0.79 P4HTM (0.54) P4HTMNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553845-B2 Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives SANOFI-AVENTIS (FR) 2009-06-30 US disclosed
US-7553845-B2 Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives SANOFI-AVENTIS (FR) 2009-06-30 US disclosed
US-7553845-B2 Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives SANOFI-AVENTIS (FR) 2009-06-30 US disclosed